These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14371745)

  • 1. Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system.
    MILLIKAN CH; SIEKERT RG; SHICK RM
    Proc Staff Meet Mayo Clin; 1955 Mar; 30(6):116-26. PubMed ID: 14371745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Choice & dosage of preparation in anticoagulant therapy of thrombosis].
    MEIXNER H
    Wien Med Wochenschr; 1957 Apr; 107(16):316-9. PubMed ID: 13443316
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in cerebrovascular disease. I. The syndrome of intermittent insufficiency of the basilar arterial system.
    MILLIKAN CH; SIEKERT RG
    Proc Staff Meet Mayo Clin; 1955 Feb; 30(4):61-8. PubMed ID: 14357427
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the treatment of cerebral arterial thrombosis].
    Lebkowski J; Abramowicz S
    Pol Tyg Lek; 1965 Dec; 20(49):1859-60. PubMed ID: 5862124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vitamin E versus coumarin and heparin therapy of thrombosis].
    KRAUS HH
    Zentralbl Gynakol; 1953; 75(32):1249-51. PubMed ID: 13123346
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin: from animal organ extract to designer drug.
    Middeldorp S
    Thromb Res; 2008; 122(6):753-62. PubMed ID: 17996279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basilar artery thrombosis: recanalisation following intravenous administration of heparin demonstrated by magnetic resonance angiography].
    Polo JM; Rivas-López MT; Ortín-Castaño A; Framiñán de Miguel A; López-Alburquerque JT; Arcaya-Navarro J
    Rev Neurol; 2004 Jul 16-31; 39(2):199-200. PubMed ID: 15264175
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute mesenteric venous occlusion, etiology unknown; case report.
    GREGORY PO
    J Maine Med Assoc; 1954 Jan; 45(1):1-2. PubMed ID: 13118300
    [No Abstract]   [Full Text] [Related]  

  • 13. [Venous thrombosis and its anticoagulant therapy; in vitro tolerance test of heparin].
    BEAUMONT JL; GERBAUX A; IENEGRE J
    Presse Med (1893); 1951 Dec; 59(79):1665-70. PubMed ID: 14900157
    [No Abstract]   [Full Text] [Related]  

  • 14. First-generation agents: aspirin, heparin and coumarins.
    Mueller RL
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):23-53. PubMed ID: 15171956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of heparin-coated stents in neurovascular interventional procedures: preliminary experience with 10 patients.
    Parkinson RJ; Demers CP; Adel JG; Levy EI; Sauvageau E; Hanel RA; Shaibani A; Guterman LR; Hopkins LN; Batjer HH; Bendok BR
    Neurosurgery; 2006 Oct; 59(4):812-21; discussion 821. PubMed ID: 17038945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK; Panhotra BR
    J Nephrol; 2005; 18(6):755-63. PubMed ID: 16358235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.